ArticlebioRxiv : the preprint server for biology2025

ALK1-BMPRII agonism by clustering bispecific antibodies treats hereditary hemorrhagic telangiectasia.

Sima Qutaina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.